These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31199957)

  • 1. DPP-4 inhibitor improves learning and memory deficits and AD-like neurodegeneration by modulating the GLP-1 signaling.
    Chen S; Zhou M; Sun J; Guo A; Fernando RL; Chen Y; Peng P; Zhao G; Deng Y
    Neuropharmacology; 2019 Oct; 157():107668. PubMed ID: 31199957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel DPP-4 inhibitor Gramcyclin A attenuates cognitive deficits in APP/PS1/tau triple transgenic mice via enhancing brain GLP-1-dependent glucose uptake.
    Li Z; Zhang Y; Meng X; Li M; Cao W; Yang J; Xu X; Liu W; Li W; Cai Q; Wang S; Ma G; Liu Z; Huang G
    Phytother Res; 2022 Mar; 36(3):1297-1309. PubMed ID: 35088915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saxagliptin: a dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer's disease.
    Kosaraju J; Gali CC; Khatwal RB; Dubala A; Chinni S; Holsinger RM; Madhunapantula VS; Muthureddy Nataraj SK; Basavan D
    Neuropharmacology; 2013 Sep; 72():291-300. PubMed ID: 23603201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xTg-AD Mouse Model of Alzheimer's Disease.
    Kosaraju J; Holsinger RMD; Guo L; Tam KY
    Mol Neurobiol; 2017 Oct; 54(8):6074-6084. PubMed ID: 27699599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dulaglutide ameliorates STZ induced AD-like impairment of learning and memory ability by modulating hyperphosphorylation of tau and NFs through GSK3β.
    Zhou M; Chen S; Peng P; Gu Z; Yu J; Zhao G; Deng Y
    Biochem Biophys Res Commun; 2019 Mar; 511(1):154-160. PubMed ID: 30773255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Native, Intact Glucagon-Like Peptide 1 Is a Natural Suppressor of Thrombus Growth Under Physiological Flow Conditions.
    Sternkopf M; Nagy M; Baaten CCFMJ; Kuijpers MJE; Tullemans BME; Wirth J; Theelen W; Mastenbroek TG; Lehrke M; Winnerling B; Baerts L; Marx N; De Meester I; Döring Y; Cosemans JMEM; Daiber A; Steven S; Jankowski J; Heemskerk JWM; Noels H
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):e65-e77. PubMed ID: 31893947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linagliptin, a DPP-4 inhibitor, ameliorates Aβ (1-42) peptides induced neurodegeneration and brain insulin resistance (BIR) via insulin receptor substrate-1 (IRS-1) in rat model of Alzheimer's disease.
    Siddiqui N; Ali J; Parvez S; Zameer S; Najmi AK; Akhtar M
    Neuropharmacology; 2021 Sep; 195():108662. PubMed ID: 34119519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.
    Chen S; An FM; Yin L; Liu AR; Yin DK; Yao WB; Gao XD
    Neuroscience; 2014 Jan; 256():137-46. PubMed ID: 24183963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vildagliptin: an anti-diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin-induced Alzheimer's disease.
    Kosaraju J; Murthy V; Khatwal RB; Dubala A; Chinni S; Muthureddy Nataraj SK; Basavan D
    J Pharm Pharmacol; 2013 Dec; 65(12):1773-84. PubMed ID: 24117480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipeptidyl peptidase-4 inhibition by Pterocarpus marsupium and Eugenia jambolana ameliorates streptozotocin induced Alzheimer's disease.
    Kosaraju J; Madhunapantula SV; Chinni S; Khatwal RB; Dubala A; Muthureddy Nataraj SK; Basavan D
    Behav Brain Res; 2014 Jul; 267():55-65. PubMed ID: 24667360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Dipeptidyl Peptidase-IV Inhibitor Sitagliptin on Extracellular Signal-Regulated Kinases 1/2 Signaling in Rats with Diabetic Nephropathy.
    Ren X; Liu G; Wang Y; Zhang W; Xue F; Li R; Yu W
    Pharmacology; 2017; 100(1-2):1-13. PubMed ID: 28329747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sitagliptin protects the cognition function of the Alzheimer's disease mice through activating glucagon-like peptide-1 and BDNF-TrkB signalings.
    Dong Q; Teng SW; Wang Y; Qin F; Li Y; Ai LL; Yu H
    Neurosci Lett; 2019 Mar; 696():184-190. PubMed ID: 30597232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological and pharmacological mechanisms through which the DPP-4 inhibitor sitagliptin regulates glycemia in mice.
    Waget A; Cabou C; Masseboeuf M; Cattan P; Armanet M; Karaca M; Castel J; Garret C; Payros G; Maida A; Sulpice T; Holst JJ; Drucker DJ; Magnan C; Burcelin R
    Endocrinology; 2011 Aug; 152(8):3018-29. PubMed ID: 21673098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term inhibition of dipeptidyl peptidase-4 in Alzheimer's prone mice.
    D'Amico M; Di Filippo C; Marfella R; Abbatecola AM; Ferraraccio F; Rossi F; Paolisso G
    Exp Gerontol; 2010 Mar; 45(3):202-7. PubMed ID: 20005285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLP-1 receptor agonists downregulate aberrant GnT-III expression in Alzheimer's disease models through the Akt/GSK-3β/β-catenin signaling.
    Wang Y; Chen S; Xu Z; Chen S; Yao W; Gao X
    Neuropharmacology; 2018 Mar; 131():190-199. PubMed ID: 29223528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide-1 response to whey protein is less diminished by dipeptidyl peptidase-4 in comparison with responses to dextrin, a lipid and casein in rats.
    Shimizu Y; Hara H; Hira T
    Br J Nutr; 2021 Feb; 125(4):398-407. PubMed ID: 32713353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DA5-CH, a novel GLP-1/GIP dual agonist, effectively ameliorates the cognitive impairments and pathology in the APP/PS1 mouse model of Alzheimer's disease.
    Cao Y; Hölscher C; Hu MM; Wang T; Zhao F; Bai Y; Zhang J; Wu MN; Qi JS
    Eur J Pharmacol; 2018 May; 827():215-226. PubMed ID: 29551659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the incretin pathway in the pathogenesis of type 2 diabetes mellitus.
    Freeman JS
    Cleve Clin J Med; 2009 Dec; 76 Suppl 5():S12-9. PubMed ID: 19952298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical administration of DPP-IV inhibitors prevents retinal neurodegeneration in experimental diabetes.
    Hernández C; Bogdanov P; Solà-Adell C; Sampedro J; Valeri M; Genís X; Simó-Servat O; García-Ramírez M; Simó R
    Diabetologia; 2017 Nov; 60(11):2285-2298. PubMed ID: 28779212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-Like Peptide-1 Mediates the Protective Effect of the Dipeptidyl Peptidase IV Inhibitor on Renal Fibrosis via Reducing the Phenotypic Conversion of Renal Microvascular Cells in Monocrotaline-Treated Rats.
    Xu J; Wang J; Cheng Y; Li X; He M; Zhu J; Han H; Wei G; Kong H; Xie W; Wang H; Zuo X
    Biomed Res Int; 2018; 2018():1864107. PubMed ID: 29607314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.